Masimo Corporation
 (MASI)

- NASDAQ
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Oct. 1, 2014, 6:33 PM
    • A Delaware jury has ruled Philips (PHG -2.2%) should pay Masimo (MASI +12.9%) $466M for infringing patents related to fingertip devices that measure blood oxygen and pulse rates. It also cleared Masimo of infringing a Philips patent.
    • Philips will almost certainly appeal the ruling, which has led Masimo shares to soar.
    • Masimo originally sued Philips in 2009. Philips has been arguing Masimo's patents are invalid due to the obviousness of the technology, and because the patent filings were poorly written.
    | Oct. 1, 2014, 6:33 PM | 1 Comment
  • Aug. 8, 2014, 3:49 PM
    • First the good news:
    • Tekmira (TKMR +38.1%) on a massive 25M share turnover; Raptor Pharmaceuticals (RPTP +28.2%) on a 4x surge in volume; Clovis Oncology (CLVS +11.6%) on 50% higher volume; RadNet (RDNT +20.4%) on 2x higher volume and Relypsa (RLYP +15%) on 2x higher volume.
    • Now the bad news:
    • TearLab (TEAR -21.2%) on 4x higher volume; Masimo (MASI -10.6%) on 3x higher volume; Volcano (VOLC -19.9%) on a 12x surge in volume and Hanger (HGR -24.9%) on a 16x surge in volume.
    | Aug. 8, 2014, 3:49 PM | 1 Comment
  • Feb. 10, 2012, 10:43 AM

    Masimo (MASI -3.2%) dips after being cut to Sell from Neutral at Citigroup on on concerns over margin compression and limited adoption of its technology among hospital customers.

    | Feb. 10, 2012, 10:43 AM
  • Oct. 25, 2011, 5:08 PM

    Masimo (MASI), a maker of patient monitoring systems, gains 2.1% AH in spite of reporting Q3 revenue of $104M (+3 % Y/Y) and EPS $0.24, missing consensus by $5.7M and $0.03. Masimo is also lowering its 2011 EPS guidance to $1.04-$1.06, from a prior range of $1.17-$1.25.

    | Oct. 25, 2011, 5:08 PM
Company Description
Masimo Corp is a medical technology company. The Company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.